{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:25:48Z","timestamp":1794875148245,"version":"4.9.1"},"reference-count":258,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41581-025-00963-0","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:41:39Z","timestamp":1745559699000},"page":"536-552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Drivers and mechanisms of cognitive decline in chronic kidney disease"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3469-8614","authenticated-orcid":false,"given":"Giovambattista","family":"Capasso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1004-9994","authenticated-orcid":false,"given":"Casper F. M.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-9392","authenticated-orcid":false,"given":"Alessandra F.","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert I.","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-1996","authenticated-orcid":false,"given":"Carmine","family":"Zoccali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tessitore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6502-6031","authenticated-orcid":false,"given":"Maiken","family":"Nedergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0801-0532","authenticated-orcid":false,"given":"Mark D.","family":"Okusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-9523","authenticated-orcid":false,"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9874-8898","authenticated-orcid":false,"given":"Carsten A.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7839-6031","authenticated-orcid":false,"given":"Robert J.","family":"Unwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"963_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration.","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709\u2013733 (2020).","journal-title":"Lancet"},{"key":"963_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41581-020-0266-9","volume":"16","author":"D Viggiano","year":"2020","unstructured":"Viggiano, D. et al. Mechanisms of cognitive dysfunction in CKD. Nat. Rev. Nephrol. 16, 452\u2013469 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"963_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jmri.27419","volume":"55","author":"A de Boer","year":"2022","unstructured":"de Boer, A. et al. Consensus-based technical recommendations for clinical translation of renal phase contrast MRI. J. Magn. Reson. Imaging 55, 323\u2013335 (2022).","journal-title":"J. Magn. Reson. Imaging"},{"key":"963_CR4","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1021\/pr200093w","volume":"10","author":"WR Wikoff","year":"2011","unstructured":"Wikoff, W. R., Nagle, M. A., Kouznetsova, V. L., Tsigelny, I. F. & Nigam, S. K. Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J. Proteome Res. 10, 2842\u20132851 (2011).","journal-title":"J. Proteome Res."},{"key":"963_CR5","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.2215\/CJN.02660221","volume":"16","author":"MH Rosner","year":"2021","unstructured":"Rosner, M. H. et al. Classification of uremic toxins and their role in kidney failure. Clin. J. Am. Soc. Nephrol. 16, 1918\u20131928 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"963_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/sj.ki.5000070","volume":"69","author":"AF Perna","year":"2006","unstructured":"Perna, A. F. et al. Increased plasma protein homocysteinylation in hemodialysis patients. Kidney Int. 69, 869\u2013876 (2006).","journal-title":"Kidney Int."},{"key":"963_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66421-y","volume":"10","author":"M Karbowska","year":"2020","unstructured":"Karbowska, M. et al. Neurobehavioral effects of uremic toxin-indoxyl sulfate in the rat model. Sci. Rep. 10, 9483 (2020).","journal-title":"Sci. Rep."},{"key":"963_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.ajkd.2023.11.013","volume":"84","author":"KE Wulczyn","year":"2024","unstructured":"Wulczyn, K. E. et al. Metabolites associated with uremic symptoms in patients with CKD: findings from the chronic renal insufficiency cohort (CRIC) study. Am. J. Kidney Dis. 84, 49\u201361.e1 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"963_CR9","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1016\/j.ekir.2024.06.039","volume":"9","author":"S Al Awadhi","year":"2024","unstructured":"Al Awadhi, S. et al. A metabolomics approach to identify metabolites associated with mortality in patients receiving maintenance hemodialysis. Kidney Int. Rep. 9, 2718\u20132726 (2024).","journal-title":"Kidney Int. Rep."},{"key":"963_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000530635","volume":"9","author":"S Xu","year":"2023","unstructured":"Xu, S. et al. Cognitive impairment in chronic kidney disease is associated with glymphatic system dysfunction. Kidney Dis. 9, 384\u2013397 (2023).","journal-title":"Kidney Dis."},{"key":"963_CR11","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/ndt\/gfae079","volume":"39","author":"DM Kelly","year":"2024","unstructured":"Kelly, D. M. et al. Impaired kidney function, cerebral small vessel disease and cognitive disorders: the Framingham Heart Study. Nephrol. Dial. Transpl. 39, 1911\u20131922 (2024).","journal-title":"Nephrol. Dial. Transpl."},{"key":"963_CR12","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1111\/ene.15928","volume":"30","author":"M P\u00e9pin","year":"2023","unstructured":"P\u00e9pin, M. et al. Cognitive disorders in patients with chronic kidney disease: approaches to prevention and treatment. Eur. J. Neurol. 30, 2899\u20132911 (2023).","journal-title":"Eur. J. Neurol."},{"key":"963_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1525-139X.2009.00577.x","volume":"22","author":"PP De Deyn","year":"2009","unstructured":"De Deyn, P. P., Vanholder, R., Eloot, S. & Glorieux, G. Guanidino compounds as uremic (neuro)toxins. Semin. Dial. 22, 340\u2013345 (2009).","journal-title":"Semin. Dial."},{"key":"963_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/jnc.15774","volume":"165","author":"P Meera","year":"2023","unstructured":"Meera, P., Uusi-Oukari, M., Wallner, M. & Lipshutz, G. S. Guanidinoacetate (GAA) is a potent GABAA receptor GABA mimetic: implications for neurological disease pathology. J. Neurochem. 165, 445\u2013454 (2023).","journal-title":"J. Neurochem."},{"key":"963_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.seizure.2013.04.015","volume":"22","author":"LJ Greenfield Jr.","year":"2013","unstructured":"Greenfield, L. J. Jr. Molecular mechanisms of antiseizure drug activity at GABAA receptors. Seizure 22, 589\u2013600 (2013).","journal-title":"Seizure"},{"key":"963_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neuro.2016.01.006","volume":"53","author":"YC Yeh","year":"2016","unstructured":"Yeh, Y. C. et al. Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease. Neurotoxicology 53, 148\u2013152 (2016).","journal-title":"Neurotoxicology"},{"key":"963_CR17","doi-asserted-by":"publisher","first-page":"774","DOI":"10.23876\/j.krcp.23.005","volume":"43","author":"SH Jeong","year":"2023","unstructured":"Jeong, S. H. et al. Indoxyl sulfate induces apoptotic cell death by inhibiting glycolysis in human astrocytes. Kidney Res. Clin. Pract. 43, 774\u2013784 (2023).","journal-title":"Kidney Res. Clin. Pract."},{"key":"963_CR18","doi-asserted-by":"publisher","unstructured":"Sato, E. et al. Impact of the oral adsorbent AST-120 on organ-specific accumulation of uremic toxins: LC-MS\/MS and MS imaging techniques. Toxins https:\/\/doi.org\/10.3390\/toxins10010019 (2017).","DOI":"10.3390\/toxins10010019"},{"key":"963_CR19","doi-asserted-by":"publisher","first-page":"106462","DOI":"10.1016\/j.ejps.2023.106462","volume":"187","author":"Q Faucher","year":"2023","unstructured":"Faucher, Q., van der Made, T. K., De Lange, E. & Masereeuw, R. Blood\u2013brain barrier perturbations by uremic toxins: key contributors in chronic kidney disease-induced neurological disorders? Eur. J. Pharm. Sci. 187, 106462 (2023).","journal-title":"Eur. J. Pharm. Sci."},{"key":"963_CR20","doi-asserted-by":"publisher","first-page":"6788","DOI":"10.1007\/s12035-024-03995-y","volume":"61","author":"GS Chai","year":"2024","unstructured":"Chai, G. S. et al. H3K4 trimethylation mediate hyperhomocysteinemia induced neurodegeneration via suppressing histone acetylation by ANP32A. Mol. Neurobiol. 61, 6788\u20136804 (2024).","journal-title":"Mol. Neurobiol."},{"key":"963_CR21","doi-asserted-by":"publisher","unstructured":"Ingrosso, D. & Perna, A. F. DNA methylation dysfunction in chronic kidney disease. Genes https:\/\/doi.org\/10.3390\/genes11070811 (2020).","DOI":"10.3390\/genes11070811"},{"key":"963_CR22","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1097\/01.ASN.0000141041.71717.11","volume":"15","author":"AF Perna","year":"2004","unstructured":"Perna, A. F. et al. Plasma protein aspartyl damage is increased in hemodialysis patients: studies on causes and consequences. J. Am. Soc. Nephrol. 15, 2747\u20132754 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR23","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang, W. H. et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368, 1575\u20131584 (2013).","journal-title":"N. Engl. J. Med."},{"key":"963_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12768","volume":"17","author":"D Li","year":"2018","unstructured":"Li, D. et al. Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice. Aging Cell 17, e12768 (2018).","journal-title":"Aging Cell"},{"key":"963_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbi.2025.03.017","volume":"127","author":"M Morrens","year":"2025","unstructured":"Morrens, M. The role of the kynurenine pathway in cognitive function in brain disorders: insights and challenges. Brain Behav. Immun. 127, 110\u2013111 (2025).","journal-title":"Brain Behav. Immun."},{"key":"963_CR26","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1021\/acschemneuro.7b00229","volume":"8","author":"GS Deora","year":"2017","unstructured":"Deora, G. S. et al. Multifunctional analogs of kynurenic acid for the treatment of Alzheimer\u2019s disease: synthesis, pharmacology, and molecular modeling studies. ACS Chem. Neurosci. 8, 2667\u20132675 (2017).","journal-title":"ACS Chem. Neurosci."},{"key":"963_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jns.2011.07.021","volume":"310","author":"N Szabo","year":"2011","unstructured":"Szabo, N., Kincses, Z. T., Toldi, J. & Vecsei, L. Altered tryptophan metabolism in Parkinson\u2019s disease: a possible novel therapeutic approach. J. Neurol. Sci. 310, 256\u2013260 (2011).","journal-title":"J. Neurol. Sci."},{"key":"963_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00702-010-0573-6","volume":"118","author":"D Zadori","year":"2011","unstructured":"Zadori, D. et al. Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington\u2019s disease. J. Neural Transm. 118, 865\u2013875 (2011).","journal-title":"J. Neural Transm."},{"key":"963_CR29","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y. & Smith, Q. R. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 56, 2007\u20132017 (1991).","journal-title":"J. Neurochem."},{"key":"963_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0014-4886(89)90149-0","volume":"106","author":"A Vezzani","year":"1989","unstructured":"Vezzani, A. et al. Studies on the potential neurotoxic and convulsant effects of increased blood levels of quinolinic acid in rats with altered blood\u2013brain barrier permeability. Exp. Neurol. 106, 90\u201398 (1989).","journal-title":"Exp. Neurol."},{"key":"963_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006344","volume":"4","author":"A Rahman","year":"2009","unstructured":"Rahman, A. et al. The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PLoS ONE 4, e6344 (2009).","journal-title":"PLoS ONE"},{"key":"963_CR32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1523\/JNEUROSCI.08-03-00975.1988","volume":"8","author":"C K\u00f6hler","year":"1988","unstructured":"K\u00f6hler, C. et al. Quinolinic acid metabolism in the rat brain. Immunohistochemical identification of 3-hydroxyanthranilic acid oxygenase and quinolinic acid phosphoribosyltransferase in the hippocampal region. J. Neurosci. 8, 975\u2013987 (1988).","journal-title":"J. Neurosci."},{"key":"963_CR33","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski, J., Floege, J., Fliser, D., B\u00f6hm, M. & Marx, N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143, 1157\u20131172 (2021).","journal-title":"Circulation"},{"key":"963_CR34","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1161\/STROKEAHA.120.029680","volume":"52","author":"DM Kelly","year":"2021","unstructured":"Kelly, D. M. et al. Chronic kidney disease and cerebrovascular disease: consensus and guidance from a KDIGO controversies conference. Stroke 52, e328\u2013e346 (2021).","journal-title":"Stroke"},{"key":"963_CR35","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.11.016","volume":"25","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Association between low estimated glomerular filtration rate and risk of cerebral small-vessel diseases: a meta-analysis. J. Stroke Cerebrovasc. Dis. 25, 710\u2013716 (2016).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"963_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-018-0014-y","volume":"14","author":"A Ter Telgte","year":"2018","unstructured":"Ter Telgte, A. et al. Cerebral small vessel disease: from a focal to a global perspective. Nat. Rev. Neurol. 14, 387\u2013398 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"963_CR37","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.kint.2018.04.022","volume":"94","author":"S Sedaghat","year":"2018","unstructured":"Sedaghat, S. et al. The AGES-Reykjavik Study suggests that change in kidney measures is associated with subclinical brain pathology in older community-dwelling persons. Kidney Int. 94, 608\u2013615 (2018).","journal-title":"Kidney Int."},{"key":"963_CR38","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s00330-015-3968-9","volume":"26","author":"G Zheng","year":"2016","unstructured":"Zheng, G. et al. Elevated global cerebral blood flow, oxygen extraction fraction and unchanged metabolic rate of oxygen in young adults with end-stage renal disease: an MRI study. Eur. Radiol. 26, 1732\u20131741 (2016).","journal-title":"Eur. Radiol."},{"key":"963_CR39","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1212\/WNL.0000000000002527","volume":"86","author":"MK Tamura","year":"2016","unstructured":"Tamura, M. K. et al. Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults. Neurology 86, 1208\u20131216 (2016).","journal-title":"Neurology"},{"key":"963_CR40","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1681\/ASN.0000000000000185","volume":"34","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Dysfunctional coupling of cerebral blood flow and susceptibility value in the bilateral hippocampus is associated with cognitive decline in nondialysis patients with CKD. J. Am. Soc. Nephrol. 34, 1574\u20131588 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70151","volume":"30","author":"L Song","year":"2024","unstructured":"Song, L. et al. Combination of rs-fMRI, QSM, and ASL reveals the cerebral neurovascular coupling dysfunction is associated with cognitive decline in patients with chronic kidney disease. CNS Neurosci. Ther. 30, e70151 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"963_CR42","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1681\/ASN.2016060704","volume":"28","author":"C MacEwen","year":"2017","unstructured":"MacEwen, C., Sutherland, S., Daly, J., Pugh, C. & Tarassenko, L. Relationship between hypotension and cerebral ischemia during hemodialysis. J. Am. Soc. Nephrol. 28, 2511\u20132520 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR43","doi-asserted-by":"publisher","first-page":"765924","DOI":"10.3389\/fmed.2021.765924","volume":"8","author":"F Inserra","year":"2021","unstructured":"Inserra, F., Forcada, P., Castellaro, A. & Castellaro, C. Chronic kidney disease and arterial stiffness: a two-way path. Front. Med. 8, 765924 (2021).","journal-title":"Front. Med."},{"key":"963_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00109-021-02037-7","volume":"99","author":"P Dusing","year":"2021","unstructured":"Dusing, P. et al. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches. J. Mol. Med. 99, 335\u2013348 (2021).","journal-title":"J. Mol. Med."},{"key":"963_CR45","doi-asserted-by":"publisher","unstructured":"Roumeliotis, S., Mallamaci, F. & Zoccali, C. Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm9082359 (2020).","DOI":"10.3390\/jcm9082359"},{"key":"963_CR46","doi-asserted-by":"publisher","first-page":"147804","DOI":"10.1016\/j.brainres.2022.147804","volume":"1780","author":"P Stoddart","year":"2022","unstructured":"Stoddart, P., Satchell, S. C. & Ramnath, R. Cerebral microvascular endothelial glycocalyx damage, its implications on the blood\u2013brain barrier and a possible contributor to cognitive impairment. Brain Res. 1780, 147804 (2022).","journal-title":"Brain Res."},{"key":"963_CR47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/sj.ki.5001511","volume":"70","author":"A Kruger","year":"2006","unstructured":"Kruger, A. et al. Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk. Kidney Int. 70, 157\u2013164 (2006).","journal-title":"Kidney Int."},{"key":"963_CR48","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2215\/CJN.08160813","volume":"9","author":"MJ Dane","year":"2014","unstructured":"Dane, M. J. et al. Association of kidney function with changes in the endothelial surface layer. Clin. J. Am. Soc. Nephrol. 9, 698\u2013704 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"963_CR49","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1681\/ASN.2011121181","volume":"23","author":"CA Vlahu","year":"2012","unstructured":"Vlahu, C. A. et al. Damage of the endothelial glycocalyx in dialysis patients. J. Am. Soc. Nephrol. 23, 1900\u20131908 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR50","doi-asserted-by":"publisher","first-page":"16281","DOI":"10.1073\/pnas.0707791104","volume":"104","author":"H Oberleithner","year":"2007","unstructured":"Oberleithner, H. et al. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc. Natl Acad. Sci. USA 104, 16281\u201316286 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"963_CR51","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1681\/ASN.2019070728","volume":"31","author":"M Bobot","year":"2020","unstructured":"Bobot, M. et al. Uremic toxic blood\u2013brain barrier disruption mediated by AhR activation leads to cognitive impairment during experimental renal dysfunction. J. Am. Soc. Nephrol. 31, 1509\u20131521 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR52","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1681\/ASN.0000000000000167","volume":"34","author":"A Gupta","year":"2023","unstructured":"Gupta, A. et al. Blood-brain barrier permeability in ESKD \u2013 a proof-of-concept study. J. Am. Soc. Nephrol. 34, 1508\u20131511 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR53","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1016\/j.ekir.2024.07.021","volume":"9","author":"M Bobot","year":"2024","unstructured":"Bobot, M. et al. Increased blood\u2013brain barrier permeability and cognitive impairment in patients with ESKD. Kidney Int. Rep. 9, 2988\u20132995 (2024).","journal-title":"Kidney Int. Rep."},{"key":"963_CR54","first-page":"10972","volume":"15","author":"H Matsuki","year":"2023","unstructured":"Matsuki, H. et al. Chronic kidney disease causes blood\u2013brain barrier breakdown via urea-activated matrix metalloproteinase-2 and insolubility of tau protein. Aging 15, 10972\u201310995 (2023).","journal-title":"Aging"},{"key":"963_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08387-7","volume":"12","author":"L Hernandez","year":"2022","unstructured":"Hernandez, L. et al. Blood\u2013brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins. Sci. Rep. 12, 4414 (2022).","journal-title":"Sci. Rep."},{"key":"963_CR56","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney, M. D., Sagare, A. P. & Zlokovic, B. V. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133\u2013150 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"963_CR57","doi-asserted-by":"publisher","first-page":"787370","DOI":"10.3389\/fneur.2021.787370","volume":"12","author":"K Crowe","year":"2021","unstructured":"Crowe, K., Quinn, T. J., Mark, P. B. & Findlay, M. D. \u201cIs it removed during dialysis?\u201d \u2013 Cognitive dysfunction in advanced kidney failure \u2013 a review article. Front. Neurol. 12, 787370 (2021).","journal-title":"Front. Neurol."},{"key":"963_CR58","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.kint.2016.11.015","volume":"91","author":"M Kurella Tamura","year":"2017","unstructured":"Kurella Tamura, M. et al. Loss of executive function after dialysis initiation in adults with chronic kidney disease. Kidney Int. 91, 948\u2013953 (2017).","journal-title":"Kidney Int."},{"key":"963_CR59","first-page":"89","volume":"10","author":"O Iyasere","year":"2017","unstructured":"Iyasere, O., Okai, D. & Brown, E. Cognitive function and advanced kidney disease: longitudinal trends and impact on decision-making. Clin. Kidney J. 10, 89\u201394 (2017).","journal-title":"Clin. Kidney J."},{"key":"963_CR60","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1681\/ASN.2013101086","volume":"26","author":"MT Eldehni","year":"2015","unstructured":"Eldehni, M. T., Odudu, A. & McIntyre, C. W. Randomized clinical trial of dialysate cooling and effects on brain white matter. J. Am. Soc. Nephrol. 26, 957\u2013965 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR61","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1681\/ASN.2012080841","volume":"24","author":"AM Murray","year":"2013","unstructured":"Murray, A. M., Seliger, S., Lakshminarayan, K., Herzog, C. A. & Solid, C. A. Incidence of stroke before and after dialysis initiation in older patients. J. Am. Soc. Nephrol. 24, 1166\u20131173 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR62","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.kint.2017.07.022","volume":"93","author":"D Neumann","year":"2018","unstructured":"Neumann, D., Mau, W., Wienke, A. & Girndt, M. Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course. Kidney Int. 93, 430\u2013438 (2018).","journal-title":"Kidney Int."},{"key":"963_CR63","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1681\/ASN.2017101088","volume":"29","author":"HA Polinder-Bos","year":"2018","unstructured":"Polinder-Bos, H. A. et al. Hemodialysis induces an acute decline in cerebral blood flow in elderly patients. J. Am. Soc. Nephrol. 29, 1317\u20131325 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR64","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1681\/ASN.0000000000000105","volume":"34","author":"UC Anazodo","year":"2023","unstructured":"Anazodo, U. C. et al. Hemodialysis-related acute brain injury demonstrated by application of intradialytic magnetic resonance imaging and spectroscopy. J. Am. Soc. Nephrol. 34, 1090\u20131104 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR65","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1681\/ASN.2021101353","volume":"33","author":"WT Richerson","year":"2022","unstructured":"Richerson, W. T., Schmit, B. D. & Wolfgram, D. F. The relationship between cerebrovascular reactivity and cerebral oxygenation during hemodialysis. J. Am. Soc. Nephrol. 33, 1602\u20131612 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR66","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1681\/ASN.2020050584","volume":"32","author":"RJ Lepping","year":"2021","unstructured":"Lepping, R. J. et al. Normalization of cerebral blood flow, neurochemicals, and white matter integrity after kidney transplantation. J. Am. Soc. Nephrol. 32, 177\u2013187 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0745-9","volume":"14","author":"I Berger","year":"2016","unstructured":"Berger, I. et al. Cognition in chronic kidney disease: a systematic review and meta-analysis. BMC Med. 14, 206 (2016).","journal-title":"BMC Med."},{"key":"963_CR68","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.cger.2013.07.002","volume":"29","author":"CN Harada","year":"2013","unstructured":"Harada, C. N., Natelson Love, M. C. & Triebel, K. L. Normal cognitive aging. Clin. Geriatr. Med. 29, 737\u2013752 (2013).","journal-title":"Clin. Geriatr. Med."},{"key":"963_CR69","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrneph.2014.185","volume":"10","author":"JP Kooman","year":"2014","unstructured":"Kooman, J. P., Kotanko, P., Schols, A. M., Shiels, P. G. & Stenvinkel, P. Chronic kidney disease and premature ageing. Nat. Rev. Nephrol. 10, 732\u2013742 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"963_CR70","doi-asserted-by":"publisher","first-page":"ii31","DOI":"10.1093\/ndt\/gfaa006","volume":"35","author":"L Dai","year":"2020","unstructured":"Dai, L., Schurgers, L. J., Shiels, P. G. & Stenvinkel, P. Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage. Nephrol. Dial. Transpl. 35, ii31\u2013ii37 (2020).","journal-title":"Nephrol. Dial. Transpl."},{"key":"963_CR71","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1083\/jcb.201708092","volume":"217","author":"D McHugh","year":"2018","unstructured":"McHugh, D. & Gil, J. Senescence and aging: causes, consequences, and therapeutic avenues. J. Cell Biol. 217, 65\u201377 (2018).","journal-title":"J. Cell Biol."},{"key":"963_CR72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco, R., Krizhanovsky, V., Baker, D. & d\u2019Adda di Fagagna, F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 22, 75\u201395 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"963_CR73","doi-asserted-by":"publisher","first-page":"646924","DOI":"10.3389\/fnagi.2021.646924","volume":"13","author":"E Sikora","year":"2021","unstructured":"Sikora, E. et al. Cellular senescence in brain aging. Front. Aging Neurosci. 13, 646924 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"963_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109228","volume":"35","author":"Y Hu","year":"2021","unstructured":"Hu, Y. et al. Replicative senescence dictates the emergence of disease-associated microglia and contributes to A\u03b2 pathology. Cell Rep. 35, 109228 (2021).","journal-title":"Cell Rep."},{"key":"963_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37304-3","volume":"14","author":"V Lau","year":"2023","unstructured":"Lau, V., Ramer, L. & Tremblay, M. E. An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer\u2019s disease. Nat. Commun. 14, 1670 (2023).","journal-title":"Nat. Commun."},{"key":"963_CR76","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1021\/acschemneuro.8b00334","volume":"9","author":"DM Angelova","year":"2018","unstructured":"Angelova, D. M. & Brown, D. R. Altered processing of \u03b2-amyloid in SH-SY5Y cells induced by model senescent microglia. ACS Chem. Neurosci. 9, 3137\u20133152 (2018).","journal-title":"ACS Chem. Neurosci."},{"key":"963_CR77","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.neuron.2016.08.009","volume":"91","author":"KM McAvoy","year":"2016","unstructured":"McAvoy, K. M. et al. Modulating neuronal competition dynamics in the dentate gyrus to rejuvenate aging memory circuits. Neuron 91, 1356\u20131373 (2016).","journal-title":"Neuron"},{"key":"963_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13296","volume":"20","author":"M Ogrodnik","year":"2021","unstructured":"Ogrodnik, M. et al. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging Cell 20, e13296 (2021).","journal-title":"Aging Cell"},{"key":"963_CR79","doi-asserted-by":"publisher","unstructured":"Kyriakidis, N. C., Cobo, G., Dai, L., Lindholm, B. & Stenvinkel, P. Role of uremic toxins in early vascular ageing and calcification. Toxins https:\/\/doi.org\/10.3390\/toxins13010026 (2021).","DOI":"10.3390\/toxins13010026"},{"key":"963_CR80","doi-asserted-by":"publisher","unstructured":"Assem, M. et al. The impact of uremic toxins on cerebrovascular and cognitive disorders. Toxins https:\/\/doi.org\/10.3390\/toxins10070303 (2018).","DOI":"10.3390\/toxins10070303"},{"key":"963_CR81","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1046\/j.1523-1755.2001.59780197.x","volume":"78","author":"BL Jaber","year":"2001","unstructured":"Jaber, B. L. et al. Apoptosis of leukocytes: basic concepts and implications in uremia. Kidney Int. Suppl. 78, S197\u2013S205 (2001).","journal-title":"Kidney Int. Suppl."},{"key":"963_CR82","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/ndt\/gfac045","volume":"38","author":"SM Laville","year":"2022","unstructured":"Laville, S. M. et al. Urea levels and cardiovascular disease in patients with chronic kidney disease. Nephrol. Dial. Transpl. 38, 184\u2013192 (2022).","journal-title":"Nephrol. Dial. Transpl."},{"key":"963_CR83","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/ki.2011.445","volume":"81","author":"CY Sun","year":"2012","unstructured":"Sun, C. Y., Chang, S. C. & Wu, M. S. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int. 81, 640\u2013650 (2012).","journal-title":"Kidney Int."},{"key":"963_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/joim.13724","volume":"295","author":"O Neytchev","year":"2024","unstructured":"Neytchev, O. et al. Epigenetic clocks indicate that kidney transplantation and not dialysis mitigate the effects of renal ageing. J. Intern. Med. 295, 79\u201390 (2024).","journal-title":"J. Intern. Med."},{"key":"963_CR85","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41514-021-00070-x","volume":"7","author":"MR Shaker","year":"2021","unstructured":"Shaker, M. R., Aguado, J., Chaggar, H. K. & Wolvetang, E. J. Klotho inhibits neuronal senescence in human brain organoids. NPJ Aging Mech. Dis. 7, 18 (2021).","journal-title":"NPJ Aging Mech. Dis."},{"key":"963_CR86","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000356212","volume":"3","author":"WT Chen","year":"2013","unstructured":"Chen, W. T. et al. Impaired leukocytes autophagy in chronic kidney disease patients. Cardiorenal Med. 3, 254\u2013264 (2013).","journal-title":"Cardiorenal Med."},{"key":"963_CR87","doi-asserted-by":"publisher","unstructured":"Lin, T. A., Wu, V. C. & Wang, C. Y. Autophagy in chronic kidney diseases. Cells https:\/\/doi.org\/10.3390\/cells8010061 (2019).","DOI":"10.3390\/cells8010061"},{"key":"963_CR88","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/ki.2012.482","volume":"83","author":"XY Dai","year":"2013","unstructured":"Dai, X. Y. et al. Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. Kidney Int. 83, 1042\u20131051 (2013).","journal-title":"Kidney Int."},{"key":"963_CR89","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000092031","volume":"26","author":"G Tsirpanlis","year":"2006","unstructured":"Tsirpanlis, G. et al. Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients. Am. J. Nephrol. 26, 91\u201396 (2006).","journal-title":"Am. J. Nephrol."},{"key":"963_CR90","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.gheart.2014.04.001","volume":"9","author":"MI Miyamoto","year":"2014","unstructured":"Miyamoto, M. I., Djabali, K. & Gordon, L. B. Atherosclerosis in ancient humans, accelerated aging syndromes and normal aging: is lamin A protein a common link? Glob. Heart 9, 211\u2013218 (2014).","journal-title":"Glob. Heart"},{"key":"963_CR91","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1161\/CIRCRESAHA.111.300543","volume":"112","author":"Y Liu","year":"2013","unstructured":"Liu, Y., Drozdov, I., Shroff, R., Beltran, L. E. & Shanahan, C. M. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ. Res. 112, e99\u2013e109 (2013).","journal-title":"Circ. Res."},{"key":"963_CR92","doi-asserted-by":"publisher","first-page":"22","DOI":"10.14283\/jpad.2021.62","volume":"9","author":"MM Gonzales","year":"2022","unstructured":"Gonzales, M. M. et al. Senolytic therapy to modulate the progression of Alzheimer\u2019s disease (SToMP-AD): a pilot clinical trial. J. Prev. Alzheimer\u2019s Dis. 9, 22\u201329 (2022).","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"963_CR93","doi-asserted-by":"publisher","first-page":"1160450","DOI":"10.3389\/fmed.2023.1160450","volume":"10","author":"F Zhang","year":"2023","unstructured":"Zhang, F., Yin, X., Huang, L. & Zhang, H. The \u201cadult inactivity triad\u201d in patients with chronic kidney disease: a review. Front. Med. 10, 1160450 (2023).","journal-title":"Front. Med."},{"key":"963_CR94","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jama.2023.15231","volume":"330","author":"DA Raichlen","year":"2023","unstructured":"Raichlen, D. A. et al. Sedentary behavior and incident dementia among older adults. JAMA 330, 934\u2013940 (2023).","journal-title":"JAMA"},{"key":"963_CR95","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","volume":"119","author":"C Zoccali","year":"2023","unstructured":"Zoccali, C. et al. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association. Cardiovasc. Res. 119, 2017\u20132032 (2023).","journal-title":"Cardiovasc. Res."},{"key":"963_CR96","doi-asserted-by":"publisher","unstructured":"Jia, R. et al. Cardiovascular disease risk models and dementia or cognitive decline: a systematic review. Front. Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2023.1257367 (2023).","DOI":"10.3389\/fnagi.2023.1257367"},{"key":"963_CR97","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1681\/ASN.2016030378","volume":"28","author":"F Manfredini","year":"2017","unstructured":"Manfredini, F. et al. Exercise in patients on dialysis: a multicenter, randomized clinical trial. J. Am. Soc. Nephrol. 28, 1259\u20131268 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR98","doi-asserted-by":"publisher","first-page":"7219461","DOI":"10.1155\/2017\/7219461","volume":"2017","author":"L Mandolesi","year":"2017","unstructured":"Mandolesi, L. et al. Environmental factors promoting neural plasticity: insights from animal and human studies. Neural Plast. 2017, 7219461 (2017).","journal-title":"Neural Plast."},{"key":"963_CR99","doi-asserted-by":"publisher","unstructured":"Loprinzi, P. D., Moore, D. & Loenneke, J. P. Does aerobic and resistance exercise influence episodic memory through unique mechanisms? Brain Sci. https:\/\/doi.org\/10.3390\/brainsci10120913 (2020).","DOI":"10.3390\/brainsci10120913"},{"key":"963_CR100","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/JNN.0b013e3182527690","volume":"44","author":"AC Sartori","year":"2012","unstructured":"Sartori, A. C., Vance, D. E., Slater, L. Z. & Crowe, M. The impact of inflammation on cognitive function in older adults: implications for healthcare practice and research. J. Neurosci. Nurs. 44, 206\u2013217 (2012).","journal-title":"J. Neurosci. Nurs."},{"key":"963_CR101","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41581-022-00675-9","volume":"19","author":"NC Bishop","year":"2023","unstructured":"Bishop, N. C. et al. Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits. Nat. Rev. Nephrol. 19, 244\u2013256 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"963_CR102","doi-asserted-by":"publisher","unstructured":"Rotondi, S. et al. Association between cognitive impairment and malnutrition in hemodialysis patients: two sides of the same coin. Nutrients https:\/\/doi.org\/10.3390\/nu15040813 (2023).","DOI":"10.3390\/nu15040813"},{"key":"963_CR103","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/ajcn\/nqac065","volume":"116","author":"ME Samson","year":"2022","unstructured":"Samson, M. E. et al. Vitamin B-12 malabsorption and renal function are critical considerations in studies of folate and vitamin B-12 interactions in cognitive performance: NHANES 2011-2014. Am. J. Clin. Nutr. 116, 74\u201385 (2022).","journal-title":"Am. J. Clin. Nutr."},{"key":"963_CR104","volume":"15","author":"MF Hossain","year":"2023","unstructured":"Hossain, M. F. et al. Prevalence of electrolyte imbalance in patients with acute stroke: a systematic review. Cureus 15, e43149 (2023).","journal-title":"Cureus"},{"key":"963_CR105","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.2215\/CJN.01360118","volume":"13","author":"C Zoccali","year":"2018","unstructured":"Zoccali, C. & Mallamaci, F. Mapping progress in reducing cardiovascular risk with kidney disease: managing volume overload. Clin. J. Am. Soc. Nephrol. 13, 1432\u20131434 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"963_CR106","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s10157-019-01819-1","volume":"24","author":"Y Otobe","year":"2020","unstructured":"Otobe, Y., Hiraki, K., Izawa, K. P., Sakurada, T. & Shibagaki, Y. Relationship between serum inorganic phosphorus levels and cognitive decline over 2 years in older adults with pre-dialysis chronic kidney disease. Clin. Exp. Nephrol. 24, 286\u2013287 (2020).","journal-title":"Clin. Exp. Nephrol."},{"key":"963_CR107","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/wcs.52","volume":"1","author":"MC Deak","year":"2010","unstructured":"Deak, M. C. & Stickgold, R. Sleep and cognition. Wiley Interdiscip. Rev. Cogn. Sci. 1, 491\u2013500 (2010).","journal-title":"Wiley Interdiscip. Rev. Cogn. Sci."},{"key":"963_CR108","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.amepre.2023.01.008","volume":"64","author":"R Wong","year":"2023","unstructured":"Wong, R. & Lovier, M. A. Sleep disturbances and dementia risk in older adults: findings from 10 years of National U.S. prospective data. Am. J. Prev. Med. 64, 781\u2013787 (2023).","journal-title":"Am. J. Prev. Med."},{"key":"963_CR109","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2215\/CJN.0000000000000504","volume":"19","author":"JJ Long","year":"2024","unstructured":"Long, J. J. et al. Sleep disorders and dementia risk in older patients with kidney failure: a retrospective cohort study. Clin. J. Am. Soc. Nephrol. 19, 1301\u20131309 (2024).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"963_CR110","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5527\/wjn.v5.i3.224","volume":"5","author":"SC Maung","year":"2016","unstructured":"Maung, S. C., El Sara, A., Chapman, C., Cohen, D. & Cukor, D. Sleep disorders and chronic kidney disease. World J. Nephrol. 5, 224\u2013232 (2016).","journal-title":"World J. Nephrol."},{"key":"963_CR111","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41581-024-00848-8","volume":"20","author":"OD Lyons","year":"2024","unstructured":"Lyons, O. D. Sleep disorders in chronic kidney disease. Nat. Rev. Nephrol. 20, 690\u2013700 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"963_CR112","doi-asserted-by":"publisher","first-page":"644","DOI":"10.23876\/j.krcp.22.112","volume":"41","author":"RA Merchant","year":"2022","unstructured":"Merchant, R. A. & Vathsala, A. Healthy aging and chronic kidney disease. Kidney Res. Clin. Pract. 41, 644\u2013656 (2022).","journal-title":"Kidney Res. Clin. Pract."},{"key":"963_CR113","doi-asserted-by":"publisher","first-page":"100458","DOI":"10.1016\/j.xkme.2022.100458","volume":"4","author":"LH Tan","year":"2022","unstructured":"Tan, L. H. et al. Insomnia and poor sleep in CKD: a systematic review and meta-analysis. Kidney Med. 4, 100458 (2022).","journal-title":"Kidney Med."},{"key":"963_CR114","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000321859","volume":"31","author":"A Pierratos","year":"2011","unstructured":"Pierratos, A. & Hanly, P. J. Sleep disorders over the full range of chronic kidney disease. Blood Purif. 31, 146\u2013150 (2011).","journal-title":"Blood Purif."},{"key":"963_CR115","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/08860220701459642","volume":"29","author":"MF Pai","year":"2007","unstructured":"Pai, M. F. et al. Sleep disturbance in chronic hemodialysis patients: the impact of depression and anemia. Ren. Fail. 29, 673\u2013677 (2007).","journal-title":"Ren. Fail."},{"key":"963_CR116","first-page":"626","volume":"24","author":"KP Parker","year":"1997","unstructured":"Parker, K. P. Sleep and dialysis: a research-based review of the literature. ANNA J. 24, 626\u2013639 (1997).","journal-title":"ANNA J."},{"key":"963_CR117","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1525-139X.2007.00384.x","volume":"21","author":"M Madero","year":"2008","unstructured":"Madero, M., Gul, A. & Sarnak, M. J. Cognitive function in chronic kidney disease. Semin. Dial. 21, 29\u201337 (2008).","journal-title":"Semin. Dial."},{"key":"963_CR118","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1038\/s41380-024-02570-0","volume":"29","author":"J You","year":"2024","unstructured":"You, J. et al. Clinical trajectories preceding incident dementia up to 15 years before diagnosis: a large prospective cohort study. Mol. Psychiatry 29, 3097\u20133105 (2024).","journal-title":"Mol. Psychiatry"},{"key":"963_CR119","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","volume":"40","author":"NA Jessen","year":"2015","unstructured":"Jessen, N. A., Munk, A. S., Lundgaard, I. & Nedergaard, M. The glymphatic system: a beginner\u2019s guide. Neurochem. Res. 40, 2583\u20132599 (2015).","journal-title":"Neurochem. Res."},{"key":"963_CR120","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway, J. M. et al. Clearance systems in the brain \u2013 implications for Alzheimer disease. Nat. Rev. Neurol. 11, 457\u2013470 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"963_CR121","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337\u2013341 (2015).","journal-title":"Nature"},{"key":"963_CR122","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1523\/JNEUROSCI.3742-14.2015","volume":"35","author":"BA Plog","year":"2015","unstructured":"Plog, B. A. et al. Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. J. Neurosci. 35, 518\u2013526 (2015).","journal-title":"J. Neurosci."},{"key":"963_CR123","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1152\/physrev.00031.2020","volume":"102","author":"MK Rasmussen","year":"2022","unstructured":"Rasmussen, M. K., Mestre, H. & Nedergaard, M. Fluid transport in the brain. Physiol. Rev. 102, 1025\u20131151 (2022).","journal-title":"Physiol. Rev."},{"key":"963_CR124","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie, L. et al. Sleep drives metabolite clearance from the adult brain. Science 342, 373\u2013377 (2013).","journal-title":"Science"},{"key":"963_CR125","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/brain\/awaa443","volume":"144","author":"PK Eide","year":"2021","unstructured":"Eide, P. K., Vinje, V., Pripp, A. H., Mardal, K. A. & Ringstad, G. Sleep deprivation impairs molecular clearance from the human brain. Brain : J. Neurol. 144, 863\u2013874 (2021).","journal-title":"Brain : J. Neurol."},{"key":"963_CR126","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1523\/JNEUROSCI.0934-21.2022","volume":"42","author":"H Helakari","year":"2022","unstructured":"Helakari, H. et al. Human NREM sleep promotes brain-wide vasomotor and respiratory pulsations. J. Neurosci. 42, 2503\u20132515 (2022).","journal-title":"J. Neurosci."},{"key":"963_CR127","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abb8739","volume":"370","author":"M Nedergaard","year":"2020","unstructured":"Nedergaard, M. & Goldman, S. A. Glymphatic failure as a final common pathway to dementia. Science 370, 50\u201356 (2020).","journal-title":"Science"},{"key":"963_CR128","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3928\/00989134-20100330-05","volume":"36","author":"KM Rose","year":"2010","unstructured":"Rose, K. M. & Lorenz, R. Sleep disturbances in dementia. J. Gerontol. Nurs. 36, 9\u201314 (2010).","journal-title":"J. Gerontol. Nurs."},{"key":"963_CR129","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2463\/mrms.rev.2023-0175","volume":"23","author":"T Taoka","year":"2024","unstructured":"Taoka, T. et al. Diffusion tensor image analysis along the perivascular space (DTI-ALPS): revisiting the meaning and significance of the method. Magn. Reson. Med. Sci. 23, 268\u2013290 (2024).","journal-title":"Magn. Reson. Med. Sci."},{"key":"963_CR130","doi-asserted-by":"publisher","first-page":"809438","DOI":"10.3389\/fneur.2021.809438","volume":"12","author":"CM Heo","year":"2021","unstructured":"Heo, C. M. et al. Glymphatic dysfunction in patients with end-stage renal disease. Front. Neurol. 12, 809438 (2021).","journal-title":"Front. Neurol."},{"key":"963_CR131","doi-asserted-by":"publisher","first-page":"2265665","DOI":"10.1080\/0886022X.2023.2265665","volume":"45","author":"YJ Lee","year":"2023","unstructured":"Lee, Y. J. et al. Changes in the glymphatic system before and after dialysis initiation in patients with end-stage kidney disease. Ren. Fail. 45, 2265665 (2023).","journal-title":"Ren. Fail."},{"key":"963_CR132","doi-asserted-by":"publisher","first-page":"976089","DOI":"10.3389\/fneur.2022.976089","volume":"13","author":"CM Heo","year":"2022","unstructured":"Heo, C. M. et al. Glymphatic system dysfunction in patients with early chronic kidney disease. Front. Neurol. 13, 976089 (2022).","journal-title":"Front. Neurol."},{"key":"963_CR133","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1177\/03913988221118941","volume":"45","author":"R Yaz\u0131c\u0131","year":"2022","unstructured":"Yaz\u0131c\u0131, R. & G\u00fcney, \u0130. Prevalence and related factors of poor sleep quality in patients with pre-dialysis chronic kidney disease. Int. J. Artif. Organs 45, 905\u2013910 (2022).","journal-title":"Int. J. Artif. Organs"},{"key":"963_CR134","first-page":"139","volume":"14","author":"B Hasanzamani","year":"2020","unstructured":"Hasanzamani, B., Pourranjbar, E. & Rezaei Ardani, A. Comparing sleep quality in patients before and after kidney transplantation. Iran. J. Kidney Dis. 14, 139\u2013144 (2020).","journal-title":"Iran. J. Kidney Dis."},{"key":"963_CR135","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s11011-020-00561-y","volume":"35","author":"CY Zhang","year":"2020","unstructured":"Zhang, C. Y., He, F. F., Su, H., Zhang, C. & Meng, X. F. Association between chronic kidney disease and Alzheimer\u2019s disease: an update. Metab. Brain Dis. 35, 883\u2013894 (2020).","journal-title":"Metab. Brain Dis."},{"key":"963_CR136","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41582-020-0312-z","volume":"16","author":"JM Wardlaw","year":"2020","unstructured":"Wardlaw, J. M. et al. Perivascular spaces in the brain: anatomy, physiology and pathology. Nat. Rev. Neurol. 16, 137\u2013153 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"963_CR137","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1111\/j.1532-5415.2004.52508.x","volume":"52","author":"M Kurella","year":"2004","unstructured":"Kurella, M., Chertow, G. M., Luan, J. & Yaffe, K. Cognitive impairment in chronic kidney disease. J. Am. Geriatr. Soc. 52, 1863\u20131869 (2004).","journal-title":"J. Am. Geriatr. Soc."},{"key":"963_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098346","volume":"9","author":"Y Qiu","year":"2014","unstructured":"Qiu, Y. et al. Structural and functional brain alterations in end stage renal disease patients on routine hemodialysis: a voxel-based morphometry and resting state functional connectivity study. PLoS ONE 9, e98346 (2014).","journal-title":"PLoS ONE"},{"key":"963_CR139","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/sdi.12686","volume":"31","author":"KL Nowak","year":"2018","unstructured":"Nowak, K. L. & Chonchol, M. Does inflammation affect outcomes in dialysis patients? Semin. Dial. 31, 388\u2013397 (2018).","journal-title":"Semin. Dial."},{"key":"963_CR140","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","volume":"58","author":"MJ Sarnak","year":"2000","unstructured":"Sarnak, M. J. & Jaber, B. L. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 58, 1758\u20131764 (2000).","journal-title":"Kidney Int."},{"key":"963_CR141","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1523-1755.2004.00781.x","volume":"66","author":"MA Verkade","year":"2004","unstructured":"Verkade, M. A. et al. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Kidney Int. 66, 614\u2013621 (2004).","journal-title":"Kidney Int."},{"key":"963_CR142","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1093\/ndt\/gfp331","volume":"24","author":"JH Stewart","year":"2009","unstructured":"Stewart, J. H. et al. The pattern of excess cancer in dialysis and transplantation. Nephrol. Dial. Transpl. 24, 3225\u20133231 (2009).","journal-title":"Nephrol. Dial. Transpl."},{"key":"963_CR143","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrneph.2013.44","volume":"9","author":"MG Betjes","year":"2013","unstructured":"Betjes, M. G. Immune cell dysfunction and inflammation in end-stage renal disease. Nat. Rev. Nephrol. 9, 255\u2013265 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"963_CR144","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3389\/fimmu.2017.00928","volume":"8","author":"H Qi","year":"2017","unstructured":"Qi, H., Yang, S. & Zhang, L. Neutrophil extracellular traps and endothelial dysfunction in atherosclerosis and thrombosis. Front. Immunol. 8, 928 (2017).","journal-title":"Front. Immunol."},{"key":"963_CR145","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","volume":"61","author":"V Mutua","year":"2021","unstructured":"Mutua, V. & Gershwin, L. J. A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics. Clin. Rev. Allergy Immunol. 61, 194\u2013211 (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"963_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00863-w","volume":"11","author":"HW Lee","year":"2021","unstructured":"Lee, H. W. et al. Uremic serum damages endothelium by provoking excessive neutrophil extracellular trap formation. Sci. Rep. 11, 21439 (2021).","journal-title":"Sci. Rep."},{"key":"963_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/cc13907","volume":"18","author":"A Nongnuch","year":"2014","unstructured":"Nongnuch, A., Panorchan, K. & Davenport, A. Brain-kidney crosstalk. Crit. Care 18, 225 (2014).","journal-title":"Crit. Care"},{"key":"963_CR148","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20230412","volume":"69","author":"RAL De Sousa","year":"2023","unstructured":"De Sousa, R. A. L. & Cassilhas, R. C. Microglia role as the regulator of cognitive function. Rev. Assoc. Med. Bras. 69, e20230412 (2023).","journal-title":"Rev. Assoc. Med. Bras."},{"key":"963_CR149","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fphar.2017.00370","volume":"8","author":"S Adesso","year":"2017","unstructured":"Adesso, S. et al. Indoxyl sulfate affects glial function increasing oxidative stress and neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia. Front. Pharmacol. 8, 370 (2017).","journal-title":"Front. Pharmacol."},{"key":"963_CR150","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ekir.2016.10.007","volume":"2","author":"M Kurella Tamura","year":"2017","unstructured":"Kurella Tamura, M. et al. Inflammatory markers and risk for cognitive decline in chronic kidney disease: the CRIC study. Kidney Int. Rep. 2, 192\u2013200 (2017).","journal-title":"Kidney Int. Rep."},{"key":"963_CR151","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5414\/CNP73036","volume":"73","author":"V Montinaro","year":"2010","unstructured":"Montinaro, V. et al. Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. Clin. Nephrol. 73, 36\u201343 (2010).","journal-title":"Clin. Nephrol."},{"key":"963_CR152","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s00213-020-05569-x","volume":"237","author":"B Zhu","year":"2020","unstructured":"Zhu, B. et al. Abnormalities in gut microbiota and serum metabolites in hemodialysis patients with mild cognitive decline: a single-center observational study. Psychopharmacology 237, 2739\u20132752 (2020).","journal-title":"Psychopharmacology"},{"key":"963_CR153","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12882-023-03410-z","volume":"24","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis. BMC Nephrol. 24, 360 (2023).","journal-title":"BMC Nephrol."},{"key":"963_CR154","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.7150\/thno.35387","volume":"9","author":"YF Wang","year":"2019","unstructured":"Wang, Y. F. et al. The gut microbiota\u2013inflammation\u2013brain axis in end-stage renal disease: perspectives from default mode network. Theranostics 9, 8171\u20138181 (2019).","journal-title":"Theranostics"},{"key":"963_CR155","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01321","volume":"420","author":"KJ Tracey","year":"2002","unstructured":"Tracey, K. J. The inflammatory reflex. Nature 420, 853\u2013859 (2002).","journal-title":"Nature"},{"key":"963_CR156","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nrneph.2017.132","volume":"13","author":"MD Okusa","year":"2017","unstructured":"Okusa, M. D., Rosin, D. L. & Tracey, K. J. Targeting neural reflex circuits in immunity to treat kidney disease. Nat. Rev. Nephrol. 13, 669\u2013680 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"963_CR157","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrn2573","volume":"10","author":"SJ Sara","year":"2009","unstructured":"Sara, S. J. The locus coeruleus and noradrenergic modulation of cognition. Nat. Rev. Neurosci. 10, 211\u2013223 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"963_CR158","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0197-0186(02)00049-9","volume":"41","author":"DL Feinstein","year":"2002","unstructured":"Feinstein, D. L. et al. Noradrenergic regulation of inflammatory gene expression in brain. Neurochem. Int. 41, 357\u2013365 (2002).","journal-title":"Neurochem. Int."},{"key":"963_CR159","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neubiorev.2014.05.005","volume":"45","author":"K Vonck","year":"2014","unstructured":"Vonck, K. et al. Vagus nerve stimulation\u202625 years later! What do we know about the effects on cognition? Neurosci. Biobehav. Rev. 45, 63\u201371 (2014).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"963_CR160","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.seizure.2006.02.014","volume":"15","author":"P Boon","year":"2006","unstructured":"Boon, P., Moors, I., De Herdt, V. & Vonck, K. Vagus nerve stimulation and cognition. Seizure 15, 259\u2013263 (2006).","journal-title":"Seizure"},{"key":"963_CR161","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1681\/ASN.2009121311","volume":"22","author":"MC Hu","year":"2011","unstructured":"Hu, M. C. et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J. Am. Soc. Nephrol. 22, 124\u2013136 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR162","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/ndt\/gfx376","volume":"33","author":"B Fernandez-Fernandez","year":"2018","unstructured":"Fernandez-Fernandez, B. et al. Albumin downregulates Klotho in tubular cells. Nephrol. Dial. Transpl. 33, 1712\u20131722 (2018).","journal-title":"Nephrol. Dial. Transpl."},{"key":"963_CR163","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1096\/fj.02-0448fje","volume":"17","author":"T Nagai","year":"2003","unstructured":"Nagai, T. et al. Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J. 17, 50\u201352 (2003).","journal-title":"FASEB J."},{"key":"963_CR164","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45\u201351 (1997).","journal-title":"Nature"},{"key":"963_CR165","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1681\/ASN.2013111209","volume":"25","author":"K Lindberg","year":"2014","unstructured":"Lindberg, K. et al. The kidney is the principal organ mediating klotho effects. J. Am. Soc. Nephrol. 25, 2169\u20132175 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"963_CR166","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1096\/fj.09-152488","volume":"24","author":"M Ohnishi","year":"2010","unstructured":"Ohnishi, M. & Razzaque, M. S. Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J. 24, 3562\u20133571 (2010).","journal-title":"FASEB J."},{"key":"963_CR167","unstructured":"Dronsfield, A. & Ellis, P. Phosphorus \u2013 food for thought. Educ. Chem. edu.rsc.org\/feature\/phosphorus-food-for-thought\/2020208.article (2009)."},{"key":"963_CR168","doi-asserted-by":"publisher","first-page":"113677","DOI":"10.1016\/j.biopha.2022.113677","volume":"154","author":"C Mora-Fernandez","year":"2022","unstructured":"Mora-Fernandez, C. et al. Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: a clinical and experimental study. Biomed. Pharmacother. 154, 113677 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"963_CR169","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.120.16635","volume":"77","author":"M Kanbay","year":"2021","unstructured":"Kanbay, M. et al. Role of Klotho in the development of essential hypertension. Hypertension 77, 740\u2013750 (2021).","journal-title":"Hypertension"},{"key":"963_CR170","doi-asserted-by":"publisher","first-page":"116203","DOI":"10.1016\/j.bcp.2024.116203","volume":"224","author":"C Favero","year":"2024","unstructured":"Favero, C., Pintor-Chocano, A., Sanz, A., Ortiz, A. & Sanchez-Nino, M. D. Butyrate promotes kidney resilience through a coordinated kidney protective response in tubular cells. Biochem. Pharmacol. 224, 116203 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"963_CR171","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.kint.2022.02.028","volume":"101","author":"L Valino-Rivas","year":"2022","unstructured":"Valino-Rivas, L. et al. Growth differentiation factor-15 preserves Klotho expression in acute kidney injury and kidney fibrosis. Kidney Int. 101, 1200\u20131215 (2022).","journal-title":"Kidney Int."},{"key":"963_CR172","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.kint.2022.11.023","volume":"103","author":"L Cuarental","year":"2023","unstructured":"Cuarental, L. et al. The transcription factor Fosl1 preserves Klotho expression and protects from acute kidney injury. Kidney Int. 103, 686\u2013701 (2023).","journal-title":"Kidney Int."},{"key":"963_CR173","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc18-0078","volume":"41","author":"JF Navarro-Gonzalez","year":"2018","unstructured":"Navarro-Gonzalez, J. F. et al. Effects of pentoxifylline on soluble klotho concentrations and renal tubular cell expression in diabetic kidney disease. Diabetes Care 41, 1817\u20131820 (2018).","journal-title":"Diabetes Care"},{"key":"963_CR174","doi-asserted-by":"publisher","first-page":"sfad276","DOI":"10.1093\/ckj\/sfad276","volume":"17","author":"M Kanbay","year":"2024","unstructured":"Kanbay, M. et al. Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease \u2013 a comprehensive review from the ERA CKD-MBD working group. Clin. Kidney J. 17, sfad276 (2024).","journal-title":"Clin. Kidney J."},{"key":"963_CR175","doi-asserted-by":"publisher","first-page":"E11388","DOI":"10.1073\/pnas.1808609115","volume":"115","author":"L Zhu","year":"2018","unstructured":"Zhu, L. et al. Klotho controls the brain\u2013immune system interface in the choroid plexus. Proc. Natl Acad. Sci. USA 115, E11388\u2013E11396 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"963_CR176","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s42003-024-06407-y","volume":"7","author":"S Dubnov","year":"2024","unstructured":"Dubnov, S. et al. Knockout of the longevity gene Klotho perturbs aging and Alzheimer\u2019s disease-linked brain microRNAs and tRNA fragments. Commun. Biol. 7, 720 (2024).","journal-title":"Commun. Biol."},{"key":"963_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39873-9","volume":"14","author":"O Leiter","year":"2023","unstructured":"Leiter, O. et al. Platelet-derived exerkine CXCL4\/platelet factor 4 rejuvenates hippocampal neurogenesis and restores cognitive function in aged mice. Nat. Commun. 14, 4375 (2023).","journal-title":"Nat. Commun."},{"key":"963_CR178","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41586-023-06436-3","volume":"620","author":"AB Schroer","year":"2023","unstructured":"Schroer, A. B. et al. Platelet factors attenuate inflammation and rescue cognition in ageing. Nature 620, 1071\u20131079 (2023).","journal-title":"Nature"},{"key":"963_CR179","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s43587-023-00468-0","volume":"3","author":"C Park","year":"2023","unstructured":"Park, C. et al. Platelet factors are induced by longevity factor klotho and enhance cognition in young and aging mice. Nat. Aging 3, 1067\u20131078 (2023).","journal-title":"Nat. Aging"},{"key":"963_CR180","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/glia.20593","volume":"56","author":"JA Duce","year":"2008","unstructured":"Duce, J. A. et al. Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey. Glia 56, 106\u2013117 (2008).","journal-title":"Glia"},{"key":"963_CR181","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s43587-023-00441-x","volume":"3","author":"SA Castner","year":"2023","unstructured":"Castner, S. A. et al. Longevity factor klotho enhances cognition in aged nonhuman primates. Nat. Aging 3, 931\u2013937 (2023).","journal-title":"Nat. Aging"},{"key":"963_CR182","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JAD-170466","volume":"61","author":"N Kuriyama","year":"2018","unstructured":"Kuriyama, N. et al. Association between \u03b1-klotho and deep white matter lesions in the brain: a pilot case control study using brain MRI. J. Alzheimers Dis. 61, 145\u2013155 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"963_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02632-x","volume":"13","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Relationship of Klotho with cognition and dementia: results from the NHANES 2011-2014 and Mendelian randomization study. Transl. Psychiatry 13, 337 (2023).","journal-title":"Transl. Psychiatry"},{"key":"963_CR184","doi-asserted-by":"publisher","unstructured":"Blizzard LeBlanc, D. R. et al. Exercise-induced irisin release as a determinant of the metabolic response to exercise training in obese youth: the EXIT trial. Physiol. Rep. https:\/\/doi.org\/10.14814\/phy2.13539 (2017).","DOI":"10.14814\/phy2.13539"},{"key":"963_CR185","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nrendo.2016.221","volume":"13","author":"N Perakakis","year":"2017","unstructured":"Perakakis, N. et al. Physiology and role of irisin in glucose homeostasis. Nat. Rev. Endocrinol. 13, 324\u2013337 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"963_CR186","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.tem.2022.06.003","volume":"33","author":"JF Bao","year":"2022","unstructured":"Bao, J. F., She, Q. Y., Hu, P. P., Jia, N. & Li, A. Irisin, a fascinating field in our times. Trends Endocrinol. Metab. 33, 601\u2013613 (2022).","journal-title":"Trends Endocrinol. Metab."},{"key":"963_CR187","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.molcel.2023.05.008","volume":"83","author":"A Mu","year":"2023","unstructured":"Mu, A. et al. Irisin acts through its integrin receptor in a two-step process involving extracellular Hsp90\u03b1. Mol. Cell 83, 1903\u20131920.e12 (2023).","journal-title":"Mol. Cell"},{"key":"963_CR188","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbi.2024.12.019","volume":"125","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Irisin reprograms microglia through activation of STAT6 and prevents cognitive dysfunction after surgery in mice. Brain Behav. Immun. 125, 68\u201391 (2025).","journal-title":"Brain Behav. Immun."},{"key":"963_CR189","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.celrep.2019.11.020","volume":"30","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Integrin \u03b1v\u03b25 internalizes Zika virus during neural stem cells infection and provides a promising target for antiviral therapy. Cell Rep. 30, 969\u2013983.e4 (2020).","journal-title":"Cell Rep."},{"key":"963_CR190","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41591-018-0275-4","volume":"25","author":"MV Lourenco","year":"2019","unstructured":"Lourenco, M. V. et al. Exercise-linked FNDC5\/irisin rescues synaptic plasticity and memory defects in Alzheimer\u2019s models. Nat. Med. 25, 165\u2013175 (2019).","journal-title":"Nat. Med."},{"key":"963_CR191","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300420R","volume":"37","author":"W Lai","year":"2023","unstructured":"Lai, W. et al. Irisin ameliorates diabetic kidney disease by restoring autophagy in podocytes. FASEB J. 37, e23175 (2023).","journal-title":"FASEB J."},{"key":"963_CR192","doi-asserted-by":"publisher","unstructured":"Bzoma, B. et al. Increased circulating irisin levels in kidney transplant patients: is there a connection with glycaemic control? Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms25052926 (2024).","DOI":"10.3390\/ijms25052926"},{"key":"963_CR193","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261459","volume":"17","author":"ML Sanchez-Tocino","year":"2022","unstructured":"Sanchez-Tocino, M. L. et al. Sarcopenia assessed by 4-step EWGSOP2 in elderly hemodialysis patients: feasibility and limitations. PLoS ONE 17, e0261459 (2022).","journal-title":"PLoS ONE"},{"key":"963_CR194","first-page":"11532","volume":"15","author":"YC Hou","year":"2023","unstructured":"Hou, Y. C. et al. Indoxyl sulfate induced frailty in patients with end-stage renal disease by disrupting the PGC-1\u03b1-FNDC5 axis. Aging 15, 11532\u201311545 (2023).","journal-title":"Aging"},{"key":"963_CR195","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cmet.2013.09.008","volume":"18","author":"CD Wrann","year":"2013","unstructured":"Wrann, C. D. et al. Exercise induces hippocampal BDNF through a PGC-1\u03b1\/FNDC5 pathway. Cell Metab. 18, 649\u2013659 (2013).","journal-title":"Cell Metab."},{"key":"963_CR196","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/path.5282","volume":"249","author":"M Fontecha-Barriuso","year":"2019","unstructured":"Fontecha-Barriuso, M. et al. PGC-1\u03b1 deficiency causes spontaneous kidney inflammation and increases the severity of nephrotoxic AKI. J. Pathol. 249, 65\u201378 (2019).","journal-title":"J. Pathol."},{"key":"963_CR197","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s11064-020-02985-5","volume":"45","author":"H Pan","year":"2020","unstructured":"Pan, H., Li, J., Zhou, Q., Zhu, F. & He, S. Protective effects of PGC-1\u03b1 on the blood brain barrier after acute kidney injury. Neurochem. Res. 45, 1086\u20131096 (2020).","journal-title":"Neurochem. Res."},{"key":"963_CR198","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12017-018-8500-3","volume":"20","author":"M Belviranli","year":"2018","unstructured":"Belviranli, M. & Okudan, N. Exercise training protects against aging-induced cognitive dysfunction via activation of the hippocampal PGC-1\u03b1\/FNDC5\/BDNF pathway. Neuromol. Med. 20, 386\u2013400 (2018).","journal-title":"Neuromol. Med."},{"key":"963_CR199","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s42255-021-00438-z","volume":"3","author":"MR Islam","year":"2021","unstructured":"Islam, M. R. et al. Exercise hormone irisin is a critical regulator of cognitive function. Nat. Metab. 3, 1058\u20131070 (2021).","journal-title":"Nat. Metab."},{"key":"963_CR200","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204835119","volume":"119","author":"TI Kam","year":"2022","unstructured":"Kam, T. I. et al. Amelioration of pathologic \u03b1-synuclein-induced Parkinson\u2019s disease by irisin. Proc. Natl Acad. Sci. USA 119, e2204835119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"963_CR201","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1016\/j.neuron.2023.08.012","volume":"111","author":"E Kim","year":"2023","unstructured":"Kim, E. et al. Irisin reduces amyloid-\u03b2 by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling. Neuron 111, 3619\u20133633.e8 (2023).","journal-title":"Neuron"},{"key":"963_CR202","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s11357-023-00770-0","volume":"45","author":"X Li","year":"2023","unstructured":"Li, X. et al. Four anti-aging drugs and calorie-restricted diet produce parallel effects in fat, brain, muscle, macrophages, and plasma of young mice. Geroscience 45, 2495\u20132510 (2023).","journal-title":"Geroscience"},{"key":"963_CR203","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s11357-023-01025-8","volume":"46","author":"M Hager","year":"2024","unstructured":"Hager, M. et al. Recapitulation of anti-aging phenotypes by global overexpression of PTEN in mice. Geroscience 46, 2653\u20132670 (2024).","journal-title":"Geroscience"},{"key":"963_CR204","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physrev.00014.2015","volume":"96","author":"S Christakos","year":"2016","unstructured":"Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L. & Carmeliet, G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiological Rev. 96, 365\u2013408 (2016).","journal-title":"Physiological Rev."},{"key":"963_CR205","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195427","volume":"13","author":"L Kagi","year":"2018","unstructured":"Kagi, L. et al. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. PLoS ONE 13, e0195427 (2018).","journal-title":"PLoS ONE"},{"key":"963_CR206","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/ndt\/gfs460","volume":"28","author":"I Pavik","year":"2013","unstructured":"Pavik, I. et al. Secreted Klotho and FGF23 in chronic kidney disease stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol. Dial. Transpl. 28, 352\u2013359 (2013).","journal-title":"Nephrol. Dial. Transpl."},{"key":"963_CR207","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/BF01711378","volume":"62","author":"S Balabanova","year":"1984","unstructured":"Balabanova, S. et al. 25-Hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid. Klin. Wochenschr. 62, 1086\u20131090 (1984).","journal-title":"Klin. Wochenschr."},{"key":"963_CR208","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.1471-4159.1985.tb08735.x","volume":"44","author":"WM Pardridge","year":"1985","unstructured":"Pardridge, W. M., Sakiyama, R. & Coty, W. A. Restricted transport of vitamin D and A derivatives through the rat blood\u2013brain barrier. J. Neurochem. 44, 1138\u20131141 (1985).","journal-title":"J. Neurochem."},{"key":"963_CR209","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jchemneu.2004.08.006","volume":"29","author":"DW Eyles","year":"2005","unstructured":"Eyles, D. W., Smith, S., Kinobe, R., Hewison, M. & McGrath, J. J. Distribution of the vitamin D receptor and 1\u03b1-hydroxylase in human brain. J. Chem. Neuroanat. 29, 21\u201330 (2005).","journal-title":"J. Chem. Neuroanat."},{"key":"963_CR210","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0891-0618(99)00002-2","volume":"16","author":"K Prufer","year":"1999","unstructured":"Prufer, K., Veenstra, T. D., Jirikowski, G. F. & Kumar, R. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J. Chem. Neuroanat. 16, 135\u2013145 (1999).","journal-title":"J. Chem. Neuroanat."},{"key":"963_CR211","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/jnr.20824","volume":"83","author":"H Taniura","year":"2006","unstructured":"Taniura, H. et al. Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J. Neurosci. Res. 83, 1179\u20131189 (2006).","journal-title":"J. Neurosci. Res."},{"key":"963_CR212","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.beem.2011.05.009","volume":"25","author":"LR Harms","year":"2011","unstructured":"Harms, L. R., Burne, T. H., Eyles, D. W. & McGrath, J. J. Vitamin D and the brain. Best. Pract. Res. Clin. Endocrinol. Metab. 25, 657\u2013669 (2011).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"963_CR213","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.brainresbull.2019.06.010","volume":"150","author":"N Sadeghian","year":"2019","unstructured":"Sadeghian, N., Shadman, J., Moradi, A., Ghasem Golmohammadi, M. & Panahpour, H. Calcitriol protects the blood\u2013brain barrier integrity against ischemic stroke and reduces vasogenic brain edema via antioxidant and antiapoptotic actions in rats. Brain Res. Bull. 150, 281\u2013289 (2019).","journal-title":"Brain Res. Bull."},{"key":"963_CR214","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3233\/JAD-140411","volume":"42","author":"MF Nissou","year":"2014","unstructured":"Nissou, M. F. et al. Additional clues for a protective role of vitamin D in neurodegenerative diseases: 1,25-dihydroxyvitamin D3 triggers an anti-inflammatory response in brain pericytes. J. Alzheimers Dis. 42, 789\u2013799 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"963_CR215","doi-asserted-by":"publisher","unstructured":"Kim, H. et al. Brain endothelial P-glycoprotein level is reduced in Parkinson\u2019s disease via a vitamin D receptor-dependent pathway. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21228538 (2020).","DOI":"10.3390\/ijms21228538"},{"key":"963_CR216","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fnins.2018.00141","volume":"12","author":"Q Liang","year":"2018","unstructured":"Liang, Q. et al. Postnatal vitamin D intake modulates hippocampal learning and memory in adult mice. Front. Neurosci. 12, 141 (2018).","journal-title":"Front. Neurosci."},{"key":"963_CR217","doi-asserted-by":"publisher","first-page":"E4359","DOI":"10.1073\/pnas.1404477111","volume":"111","author":"CS Latimer","year":"2014","unstructured":"Latimer, C. S. et al. Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc. Natl Acad. Sci. USA 111, E4359\u2013E4366 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"963_CR218","doi-asserted-by":"publisher","first-page":"967813","DOI":"10.3389\/fncel.2022.967813","volume":"16","author":"A Magdy","year":"2022","unstructured":"Magdy, A. et al. Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson\u2019s disease rat model. Front. Cell Neurosci. 16, 967813 (2022).","journal-title":"Front. Cell Neurosci."},{"key":"963_CR219","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11064-022-03728-4","volume":"48","author":"RO da Costa","year":"2023","unstructured":"da Costa, R. O. et al. Vitamin D (VD3) intensifies the effects of exercise and prevents alterations of behavior, brain oxidative stress, and neuroinflammation, in hemiparkinsonian rats. Neurochem. Res. 48, 142\u2013160 (2023).","journal-title":"Neurochem. Res."},{"key":"963_CR220","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jsbmb.2009.03.007","volume":"115","author":"T Keisala","year":"2009","unstructured":"Keisala, T. et al. Premature aging in vitamin D receptor mutant mice. J. Steroid Biochem. Mol. Biol. 115, 91\u201397 (2009).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"963_CR221","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.brainres.2011.01.056","volume":"1382","author":"A Kosakai","year":"2011","unstructured":"Kosakai, A. et al. Degeneration of mesencephalic dopaminergic neurons in klotho mouse related to vitamin D exposure. Brain Res. 1382, 109\u2013117 (2011).","journal-title":"Brain Res."},{"key":"963_CR222","doi-asserted-by":"publisher","DOI":"10.1038\/srep24879","volume":"6","author":"CB Leibrock","year":"2016","unstructured":"Leibrock, C. B., Voelkl, J., Kuro, O. M., Lang, F. & Lang, U. E. 1,25(OH)2D3 dependent overt hyperactivity phenotype in klotho-hypomorphic mice. Sci. Rep. 6, 24879 (2016).","journal-title":"Sci. Rep."},{"key":"963_CR223","doi-asserted-by":"publisher","first-page":"1377058","DOI":"10.3389\/fnagi.2024.1377058","volume":"16","author":"Y Du","year":"2024","unstructured":"Du, Y. et al. Associations of vitamin D receptor polymorphisms with risk of Alzheimer\u2019s disease, Parkinson\u2019s disease, and mild cognitive impairment: a systematic review and meta-analysis. Front. Aging Neurosci. 16, 1377058 (2024).","journal-title":"Front. Aging Neurosci."},{"key":"963_CR224","doi-asserted-by":"publisher","unstructured":"Zhou, C. et al. Serum 25-hydroxyvitamin D, vitamin D receptor, and vitamin-D-binding protein gene polymorphisms and risk of dementia among older adults with prediabetes. J. Gerontol. A Biol. Sci. Med. Sci. https:\/\/doi.org\/10.1093\/gerona\/glae015 (2024).","DOI":"10.1093\/gerona\/glae015"},{"key":"963_CR225","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/advances\/nmab074","volume":"12","author":"N Liu","year":"2021","unstructured":"Liu, N. et al. Vitamin D receptor gene polymorphisms and risk of Alzheimer disease and mild cognitive impairment: a systematic review and meta-analysis. Adv. Nutr. 12, 2255\u20132264 (2021).","journal-title":"Adv. Nutr."},{"key":"963_CR226","doi-asserted-by":"publisher","first-page":"155","DOI":"10.31083\/j.jin2106155","volume":"21","author":"CN Homann","year":"2022","unstructured":"Homann, C. N. & Homann, B. The role of vitamin D in basal ganglia diseases. J. Integr. Neurosci. 21, 155 (2022).","journal-title":"J. Integr. Neurosci."},{"key":"963_CR227","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jocn.2022.04.015","volume":"100","author":"H Wu","year":"2022","unstructured":"Wu, H. et al. Correlation between serum 25(OH)D and cognitive impairment in Parkinson\u2019s disease. J. Clin. Neurosci. 100, 192\u2013195 (2022).","journal-title":"J. Clin. Neurosci."},{"key":"963_CR228","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1002\/alz.13884","volume":"20","author":"APM van Soest","year":"2024","unstructured":"van Soest, A. P. M. et al. Concurrent nutrient deficiencies are associated with dementia incidence. Alzheimers Dement. 20, 4594\u20134601 (2024).","journal-title":"Alzheimers Dement."},{"key":"963_CR229","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3233\/JAD-231381","volume":"98","author":"XX Zhang","year":"2024","unstructured":"Zhang, X. X. et al. Association of vitamin D levels with risk of cognitive impairment and dementia: a systematic review and meta-analysis of prospective studies. J. Alzheimers Dis. 98, 373\u2013385 (2024).","journal-title":"J. Alzheimers Dis."},{"key":"963_CR230","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1001\/jamaneurol.2023.4929","volume":"81","author":"S Hendriks","year":"2024","unstructured":"Hendriks, S. et al. Risk factors for young-onset dementia in the UK biobank. JAMA Neurol. 81, 134\u2013142 (2024).","journal-title":"JAMA Neurol."},{"key":"963_CR231","volume":"15","author":"M Ghahremani","year":"2023","unstructured":"Ghahremani, M. et al. Vitamin D supplementation and incident dementia: effects of sex, APOE, and baseline cognitive status. Alzheimers Dement 15, e12404 (2023).","journal-title":"Alzheimers Dement"},{"key":"963_CR232","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3233\/JAD-221223","volume":"99","author":"Y Ilboudo","year":"2024","unstructured":"Ilboudo, Y. et al. Vitamin D, cognition, and Alzheimer\u2019s disease: observational and two-sample mendelian randomization studies. J. Alzheimers Dis. 99, 1243\u20131260 (2024).","journal-title":"J. Alzheimers Dis."},{"key":"963_CR233","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0261-5614(96)80242-1","volume":"15","author":"M Mowe","year":"1996","unstructured":"Mowe, M., Bohmer, T. & Haug, E. Serum calcidiol and calcitriol concentrations in elderly people: variations with age, sex, season and disease. Clin. Nutr. 15, 201\u2013206 (1996).","journal-title":"Clin. Nutr."},{"key":"963_CR234","doi-asserted-by":"publisher","first-page":"101089","DOI":"10.1016\/j.eujim.2020.101089","volume":"35","author":"JM Azimzadeh","year":"2020","unstructured":"Azimzadeh, J. M., Shidfar, F., Jazayeri, S., Hosseini, A. F. & Ranjbaran, F. Effect of vitamin D supplementation on klotho protein, antioxidant status and nitric oxide in the elderly: a randomized, double-blinded, placebo-controlled clinical trial. Eur. J. Integr. Med. 35, 101089 (2020).","journal-title":"Eur. J. Integr. Med."},{"key":"963_CR235","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ckj\/sfz085","volume":"13","author":"JA Neyra","year":"2020","unstructured":"Neyra, J. A. et al. Performance of soluble Klotho assays in clinical samples of kidney disease. Clin. Kidney J. 13, 235\u2013244 (2020).","journal-title":"Clin. Kidney J."},{"key":"963_CR236","doi-asserted-by":"publisher","first-page":"277","DOI":"10.20452\/pamw.1768","volume":"123","author":"T Hryszko","year":"2013","unstructured":"Hryszko, T. et al. Cholecalciferol supplementation reduces soluble Klotho concentration in hemodialysis patients. Pol. Arch. Med. Wewn. 123, 277\u2013281 (2013).","journal-title":"Pol. Arch. Med. Wewn."},{"key":"963_CR237","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1053\/j.jrn.2021.05.006","volume":"32","author":"J Etemadi","year":"2022","unstructured":"Etemadi, J. et al. The effects of cholecalciferol supplementation on FGF23 and \u03b1-klotho in hemodialysis patients with hypovitaminosis D: a randomized, double-blind, placebo-controlled trial. J. Ren. Nutr. 32, 334\u2013340 (2022).","journal-title":"J. Ren. Nutr."},{"key":"963_CR238","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ki.2012.322","volume":"82","author":"WL Lau","year":"2012","unstructured":"Lau, W. L. et al. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int. 82, 1261\u20131270 (2012).","journal-title":"Kidney Int."},{"key":"963_CR239","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ki.2015.22","volume":"87","author":"CS Ritter","year":"2015","unstructured":"Ritter, C. S., Zhang, S., Delmez, J., Finch, J. L. & Slatopolsky, E. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats. Kidney Int. 87, 1141\u20131152 (2015).","journal-title":"Kidney Int."},{"key":"963_CR240","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.24465","volume":"6","author":"M Montero-Odasso","year":"2023","unstructured":"Montero-Odasso, M. et al. Effects of exercise alone or combined with cognitive training and vitamin D supplementation to improve cognition in adults with mild cognitive impairment: a randomized clinical trial. JAMA Netw. Open. 6, e2324465 (2023).","journal-title":"JAMA Netw. Open."},{"key":"963_CR241","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/WAD.0000000000000178","volume":"30","author":"AR Zammit","year":"2016","unstructured":"Zammit, A. R., Katz, M. J., Bitzer, M. & Lipton, R. B. Cognitive impairment and dementia in older adults with chronic kidney disease: a review. Alzheimer Dis. Assoc. Disord. 30, 357\u2013366 (2016).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"963_CR242","doi-asserted-by":"publisher","first-page":"787","DOI":"10.34067\/KID.0000000000000474","volume":"5","author":"M Bobot","year":"2024","unstructured":"Bobot, M., Bruno, J. & Burtey, S. Cognitive impairment phenotypes in patients with CKD stages 3b and 4. Kidney360 5, 787\u2013788 (2024).","journal-title":"Kidney360"},{"key":"963_CR243","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3904\/kjim.2021.492","volume":"37","author":"DS Kim","year":"2022","unstructured":"Kim, D. S., Kim, S. W. & Gil, H. W. Emotional and cognitive changes in chronic kidney disease. Korean J. Intern. Med. 37, 489\u2013501 (2022).","journal-title":"Korean J. Intern. Med."},{"key":"963_CR244","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.csbj.2020.02.018","volume":"18","author":"P Wei","year":"2020","unstructured":"Wei, P., Keller, C. & Li, L. Neuropeptides in gut\u2013brain axis and their influence on host immunity and stress. Comput. Struct. Biotechnol. J. 18, 843\u2013851 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"963_CR245","doi-asserted-by":"publisher","unstructured":"Nahvi, R. J. & Sabban, E. L. Sex differences in the neuropeptide Y system and implications for stress related disorders. Biomolecules https:\/\/doi.org\/10.3390\/biom10091248 (2020).","DOI":"10.3390\/biom10091248"},{"key":"963_CR246","doi-asserted-by":"publisher","first-page":"ii14","DOI":"10.1093\/ndt\/gfab284","volume":"37","author":"C Zoccali","year":"2021","unstructured":"Zoccali, C. et al. Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges. Nephrol. Dial. Transpl. 37, ii14\u2013ii23 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"963_CR247","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/HJH.0000000000003600","volume":"42","author":"B Spoto","year":"2024","unstructured":"Spoto, B. et al. Neuropeptide Y gene polymorphisms and chronic kidney disease progression. J. Hypertens. 42, 267\u2013273 (2024).","journal-title":"J. Hypertens."},{"key":"963_CR248","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1440-1681.1975.tb02368.x","volume":"2","author":"J Sawynok","year":"1975","unstructured":"Sawynok, J. & Dawborn, J. K. Plasma concentration and urinary excretion of guanidine derivatives in normal subjects and patients with renal failure. Clin. Exp. Pharmacol. Physiol. 2, 1\u201315 (1975).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"963_CR249","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1039\/C7NP00037E","volume":"34","author":"RGS Berlinck","year":"2017","unstructured":"Berlinck, R. G. S., Bertonha, A. F., Takaki, M. & Rodriguez, J. P. G. The chemistry and biology of guanidine natural products. Nat. Prod. Rep. 34, 1264\u20131301 (2017).","journal-title":"Nat. Prod. Rep."},{"key":"963_CR250","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00109-023-02289-5","volume":"101","author":"A Salminen","year":"2023","unstructured":"Salminen, A. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer\u2019s disease: role of tryptophan metabolites generated by gut host-microbiota. J. Mol. Med. 101, 201\u2013222 (2023).","journal-title":"J. Mol. Med."},{"key":"963_CR251","doi-asserted-by":"publisher","unstructured":"Tsuji, K. et al. The gut\u2013kidney axis in chronic kidney diseases. Diagnostics https:\/\/doi.org\/10.3390\/diagnostics15010021 (2024).","DOI":"10.3390\/diagnostics15010021"},{"key":"963_CR252","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.pharep.2014.07.013","volume":"66","author":"WA Turski","year":"2014","unstructured":"Turski, W. A. et al. On the toxicity of kynurenic acid in vivo and in vitro. Pharmacol. Rep. 66, 1127\u20131133 (2014).","journal-title":"Pharmacol. Rep."},{"key":"963_CR253","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000490005","volume":"140","author":"F Stringuetta Belik","year":"2018","unstructured":"Stringuetta Belik, F. et al. Influence of intradialytic aerobic training in cerebral blood flow and cognitive function in patients with chronic kidney disease: a pilot randomized controlled trial. Nephron 140, 9\u201317 (2018).","journal-title":"Nephron"},{"key":"963_CR254","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ekir.2017.08.006","volume":"3","author":"MA McAdams-DeMarco","year":"2018","unstructured":"McAdams-DeMarco, M. A. et al. Intradialytic cognitive and exercise training may preserve cognitive function. Kidney Int. Rep. 3, 81\u201388 (2018).","journal-title":"Kidney Int. Rep."},{"key":"963_CR255","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1159\/000520230","volume":"52","author":"Y Otobe","year":"2021","unstructured":"Otobe, Y. et al. Physical exercise improves cognitive function in older adults with stage 3-4 chronic kidney disease: a randomized controlled trial. Am. J. Nephrol. 52, 929\u2013939 (2021).","journal-title":"Am. J. Nephrol."},{"key":"963_CR256","first-page":"CD014653","volume":"1","author":"A Bernier-Jean","year":"2022","unstructured":"Bernier-Jean, A. et al. Exercise training for adults undergoing maintenance dialysis. Cochrane Database Syst. Rev. 1, CD014653 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"963_CR257","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2215\/CJN.0000000000000533","volume":"19","author":"E Bradshaw","year":"2024","unstructured":"Bradshaw, E., Alejmi, A., Rossetti, G., D\u2019Avossa, G. & Macdonald, J. H. Exercise and cognitive function in chronic kidney disease: a systematic review and meta-analysis of efficacy and harms. Clin. J. Am. Soc. Nephrol. 19, 1461\u20131472 (2024).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"963_CR258","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.kint.2024.07.014","volume":"106","author":"M Rose","year":"2024","unstructured":"Rose, M. et al. The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration. Kidney Int. 106, 961\u2013971 (2024).","journal-title":"Kidney Int."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00963-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00963-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00963-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:25:11Z","timestamp":1757168711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00963-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":258,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["963"],"URL":"https:\/\/doi.org\/10.1038\/s41581-025-00963-0","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"4 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.O. has received grants from Sanofi, and consultancy or speaker fees or travel support from Adviccene, Alexion, Astellas, Astrazeneca, Amicus, Amgen, Bioporto, Boehringer Ingelheim, Esteve, Fresenius Medical Care, GSK, Bayer, Sanofi-Genzyme, Sobi, Menarini, Mundipharma, Kyowa Kirin, Lilly, Freeline, Idorsia, Chiesi, Otsuka, Novo-Nordisk, Sysmex and Vifor Fresenius Medical Care Renal Pharma and Spafarma; is the Director of the Catedra UAM-Astrazeneca of chronic kidney disease and electrolytes; and owns Telara Farma stock. C.F.M.F. received research grants from Baxter, Fresenius and Sandoz; and is on the Advisory board of Pharvaris. C.A.W. reports honoraria from Kyowa Kirin and Medice; and scientific collaboration with Bayer AG. M.D.O. is on the scientific advisory board of AstraZeneca. R.I.M. is currently employed as Senior Director Bioscience Renal, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Z.A.M. reports grants from Amgen, Baxter, Fresenius Medical Care, GlaxoSmithKline, Merck Sharp and Dohme-Chibret, Genzyme\/Sanofi, Lilly, Otsuka and Boehringer Ingelheim; Government support for CKD REIN PROJECT AND EXPERIMENTAL PROJECTS; and payment or honoraria for lectures and presentations to charities from AstraZeneca, GSK and Boehringer Ingelheim. R.J.U. is currently employed as a Chief Scientist by AstraZeneca Biopharmaceuticals R&D, Translational Science and Experimental Medicine (TSEM), and Early Cardiovascular, Renal and Metabolism (eCVRM), Cambridge, UK. M.N. is a paid consultant for CNS2 for unrelated work. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}